• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Innovation Iteration: Latest Advancements in Design & Prototyping

    Robot Recharge: Orthopedic Surgical Robotics Update

    Fine Print: Examining 3D Printing for Orthopedics

    Pulsed Electrochemical Machining: Achieved Through Chemistry

    Packaging and Sterilization Update for Orthopedic Devices
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod

    Ekso Bionics Names Jerome Wong as Interim CFO

    Exactech Completes First Surgeries Using Next-Gen Cage Glenoid

    Zimmer Biomet Promotes Keri Mattox to Chief Comm & Admin Officer

    Emovi, Geneva Foundation Providing Knee Treatment Tech to U.S. Army
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    ODT's Most Read Stories This Week—May 21

    Denise Pedulla Appointed as Chief Legal Officer at Conformis

    ODT's Most-Read Stories This Week—May 14

    Steven Haddad Joins Extremity Medical as Chief Clinical Officer

    FDA OKs Accelus' FlareHawk TiHawk11 Interbodies
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    It’s All About the Data for Supply Chain and Inventory Management

    Minimizing Risks in Minimally Invasive Surgery

    Giving Athletes Their Lives Back with Better Knee Braces

    ODT Forum '22 is Another Successful Orthopedic Tech Conference

    5 Ways AI Will Impact Orthopedic Surgery's Future
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    AV&R

    Modern Plastics

    Tiodize

    Braxton Manufacturing

    Life Science Outsourcing, Inc.
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    Bone Cancer: The Global Burden and Medtech Opportunity

    There are so many medical devices critical to the treatment of cancer.

    Bone Cancer: The Global Burden and Medtech Opportunity
    Table 1: Global osteosarcoma incidence rates per million by age group.5
    Related CONTENT
    • Medbio LLC
    • Cool Clean Technologies, LLC
    • NTK Cutting Tools
    • Evolution Devices Launches EvoWalk Platform Pilot Program
    • Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Cleared by FDA
    Maria Shepherd, President and Founder, Medi-Vantage09.14.21
    Sadly, U.S. osteosarcoma incidence rates peak in teenagers and the elderly.1,2 Using the Cancer Incidence in Five Continents (IARC database), the incidence rates for children and adolescents (ages 0-24), the 25-59-year-old group, and elderly (≥60) patients by world regions and individual countries were compared.3,4 Globally, osteosarcoma incidence rates were comparable for children and adolescents (Table 1). The greatest variation in incidence rates was observed in the elderly.

    Why This Is Important
    There are so many medical devices critical to the treatment of cancer. According to the World Health Organization, capital equipment (e.g., scopes, electrocardiography, infusion pumps, MRI, etc.) are vital tools in cancer management. So are laboratory diagnostics and pathology equipment, surgical equipment, PPE, shielding and radiation protection, imaging devices, medical furniture (like beds and IV poles), and of course, single-use medical devices. Medications such as chemotherapy and biosimilars, for those who can afford them, are also needed in the fight against cancer.

    The Impact of COVID on Cancer
    Experts are still estimating the extent of the COVID-19 pandemic’s impact around the world. Most agree, however, delays in diagnosis and treatment, patient fears of contracting COVID at a treatment facility, difficulties in gaining access to healthcare facilities due to closures or gatekeepers, and/or delayed or reduced access to screening programs are expected to cause a short-term decrease in reported cancer incidence. Further, it is predicted this period will be followed by an increase in late-stage diagnoses and cancer mortality in some areas of the world.

    COVID notwithstanding, data are available for 2020. There were an approximated 19.3 million new diagnoses of cancer and almost 10 million cancer deaths across the globe in 2020. For men and women combined, approximately 50 percent of all cancer cases and 58.3 percent of cancer deaths were assessed to have occurred in Asia in 2020. This aligns with population estimates—an estimated 59.5 percent of the global population resides in that region. Europe reported 22.8 percent of total cancer cases and 19.6 percent of cancer deaths. These numbers do not align with population estimates in Europe—9.7 percent of the global population. In North America, the incidence is 20.9 percent with 14.2 percent of deaths worldwide (Table 2). Sadly, the percentage of cancer deaths in Asia (58.3 percent, as noted above) and Africa (7.2 percent) are greater than the incidence (49.3 percent and 5.7 percent, respectively), likely caused by the different types of cancer experienced there and higher case fatality rates in many of these underserved regions. For both sexes combined, the top 10 cancers account for >60 percent of the newly diagnosed cancer cases and >70 percent of the cancer deaths.5


    Table 2: Global deaths from cancer by region in 2020.5

    Bone Metastases
    According to UpToDate, bone metastases are a common display of distant relapse from many forms of solid cancers, especially those arising in the breast, lung, and prostate, and are a prominent source of morbidity.6 Skeletal-related events (SREs) that are caused by bone metastases include pathologic fracture, pain, spinal cord compression, and hypercalcemia. Across the many types of tumors involving bone, the frequency of SREs can be reduced through the use of osteoclast inhibitors, such as bisphosphonates or Denosumab.

    Management for patients with bone metastases include decreasing pain or symptom control, preserving and restoring function, minimizing the risk for SREs, stabilizing the skeleton (if needed), and enhancing local tumor control. Therapeutic options include pain management/analgesia (which may be administered in parallel with osteoclast inhibitors), systemic anticancer therapy, radiation therapy, stereotactic body radiation therapy, bone-targeting radiopharmaceuticals, surgery for patients with a complete or impending pathologic fracture, and image-guided thermal ablation.

    Osteoclast inhibitors are indicated to manage metastatic bone disease for the majority of patients with solid tumors. Osteoclast inhibitors may slow or reverse the progression of bone metastases to reduce the occurrence of SREs. In addition, they also have modest analgesic benefit and are more frequently prescribed for the treatment of osteoporosis. In addition, in many clinical trials, Denosumab (a blockbuster drug from Amgen) proved moderately superior to bisphosphonates for the prevention of SREs and in providing an analgesic effect. However, the analgesic efficacy of these compounds is limited, and are not recommended as first-line pain-relieving agents to treat bone metastases.

    In 2008, Amgen announced promising results for its experimental osteoporosis drug Denosumab. Their goal was to take market share from Fosamax, Merck’s popular small-molecule drug.7 In phase 3 trials, Denosumab showed positive outcomes by reducing the instance of spine fractures in postmenopausal women with osteoporosis by approximately 67 percent. Denosumab (trade name Prolia) will compete for a share of the market dominated by Merck that had estimated revenues of nearly $2 billion in 2007.

    Adjust Sales and Product Development Strategies
    A very small number of highly successful products signify the top-heavy shape of the oncology drug market. The blockbusters are the first place to look for opportunities in medical devices. However, there are 28 other indications for blockbusters between $1 billion and $5 billion (where Prolia and Fosamax sit), providing another place to look for opportunity.

    The Medi-Vantage Perspective
    Strategy, strategy, strategy. Sometimes medtech innovators need to look under the most unlikely rocks to find strategic opportunity. Looking at pharma and biotech sales, especially in the highly valuable domains of oncology drugs, is one of many to start looking for opportunity. 

    References
    1. bit.ly/odt210901
    2. bit.ly/odt210902
    3. Mascarenhas, L.; Siegel, S.; Spector, L.; Arndt, C.; Femino, D.; Malogolowkin, M. Malignant bone tumors: cancer in 15- to 29-year-olds in the United States. In: Bleyer, A.; O'Leary, M.; Barr, R.; Ries, LAG., editors. Cancer Epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. Bethesda, MD: National Cancer Institute; 2006. p. 98-109.NIH Pub. No. 06-5767
    4. Parkin, DM.; Kramárová, E.; Draper, GJ.; Masuyer, E.; Michaelis, J.; Neglia, J.; Qureshi, S.; Stiller, CA. IARC Scientific Publications No. 144. Vol. vol. 2. Lyon: 1998. International incidence of childhood cancer
    5. bit.ly/odt210905
    6. bit.ly/odt210906
    7. bit.ly/odt210907


    Maria Shepherd has more than 20 years of leadership experience in medical device/life-science marketing in small startups and top-tier companies. After her industry career, including her role as vice president of marketing for Oridion Medical, where she boosted the company valuation prior to its acquisition by Medtronic, director of marketing for Philips Medical, and senior management roles at Boston Scientific Corp., she founded Medi-Vantage. Medi-Vantage provides marketing and business strategy and innovation research for the medical device industry. The firm quantitatively and qualitatively sizes and segments opportunities, evaluates new technologies, provides marketing services, and assesses prospective acquisitions. Shepherd has taught marketing and product development courses, speaks regularly at medtech conferences, and can be reached at mshepherd@medi-vantage.com. Visit her website at www.medi-vantage.com. 
    Suggested For You
    Medbio LLC Medbio LLC
    Cool Clean Technologies, LLC Cool Clean Technologies, LLC
    NTK Cutting Tools NTK Cutting Tools
    Evolution Devices Launches EvoWalk Platform Pilot Program Evolution Devices Launches EvoWalk Platform Pilot Program
    Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Cleared by FDA Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Cleared by FDA
    Exactech Exactech's Equinoxe Stemless Shoulder Replacement Debuts in Europe
    HD Lifesciences Changes Name to NanoHive Medical HD Lifesciences Changes Name to NanoHive Medical
    Accelus Introduces TiHawk9 Expandable Interbody Cage Accelus Introduces TiHawk9 Expandable Interbody Cage
    Orthofix Launches Magnesium-Based Settable Bone Void Filler Orthofix Launches Magnesium-Based Settable Bone Void Filler
    Married Patients Experience Better Outcomes After Total Joint Arthroplasty Married Patients Experience Better Outcomes After Total Joint Arthroplasty
    IncludeHealth Launches Proprietary Musculoskeletal Operating System with Google and ProMedica IncludeHealth Launches Proprietary Musculoskeletal Operating System with Google and ProMedica
    Perioperative Aspirin Use Reduces Opioid Intake After Rotator Cuff Surgery Perioperative Aspirin Use Reduces Opioid Intake After Rotator Cuff Surgery
    Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf
    NASS News: ATEC to Feature Comprehensive Procedural Solutions NASS News: ATEC to Feature Comprehensive Procedural Solutions
    Opioids are Overprescribed to Kids, Teens After Orthopedic Procedures Opioids are Overprescribed to Kids, Teens After Orthopedic Procedures

    Related Content

    • Medbio LLC

      Medbio LLC

      ...
      Shannon Warren, Marketing Specialist 05.10.22

    • Cool Clean Technologies, LLC

      ...
      Parker Nickolay, Marketing Coordinator 05.10.22

    • NTK Cutting Tools

      ...
      Melissa Singher, Senior Product / CT Coordinator 04.28.22


    • Evolution Devices Launches EvoWalk Platform Pilot Program

      Evolution Devices Launches EvoWalk Platform Pilot Program

      Aims to rehabilitate walking for people living with neurologically-based partial walking paralysis.
      Evolution Devices 09.22.21

    • Spine/Neurology
      Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Cleared by FDA

      Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Cleared by FDA

      Maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, & streamlines the implant delivery.
      Kleiner Device Labs 09.22.21


      Trending
      • Stryker Launches EasyFuse Dynamic Compression For Foot & Ankle | Orthopedic Design Technology
      • FDA Clears Anika's X-Twist Knotless Fixation System | Orthopedic Design Technology
      • FDA OKs Tenon Medical's Catamaran Sacroiliac Joint Fusion System | Orthopedic Design Technology
      • Stryker Launches EasyFuse Dynamic Compression for Foot & Ankle
      • Bioventus Launches DUROLANE In The U.S. | Orthopedic Design Technology
      Breaking News
      • ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod
      • Ekso Bionics Names Jerome Wong as Interim CFO
      • Exactech Completes First Surgeries Using Next-Gen Cage Glenoid
      • Zimmer Biomet Promotes Keri Mattox to Chief Comm & Admin Officer
      • Emovi, Geneva Foundation Providing Knee Treatment Tech to U.S. Army
      View Breaking News >
      CURRENT ISSUE

      March/April 2022

      • Innovation Iteration: Latest Advancements in Design & Prototyping
      • Robot Recharge: Orthopedic Surgical Robotics Update
      • Fine Print: Examining 3D Printing for Orthopedics

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      ICP Receives ASC Innovation Award for Spray Foam That Meets Changing Environmental Regulations
      Pylon Coatings Uses Polygiene Biomaster & Verimaster for Antimicrobial Surface Protection
      Sto Corp. Recognized with Multiple Honors at the EIFS Hero Awards
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Medtronic, DaVita to Create New Kidney Care Firm
      OmniGuide's RevoLix HTL Hybrid Thulium Laser OK'ed for BPH and Stone Treatments
      In Vitro Diagnostic Medical Devices Regulation Takes Effect
      Contract Pharma

      Latest Breaking News From Contract Pharma

      DFE Pharma Opens India CoE for Fast-Track Formulation Services
      Helsinn Establishes New R&D Hub in the U.S.
      CureVac, myNEO Partner on Antigen Targets for mRNA-Cancer Vax Development
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Carlyle To Acquire HCP Packaging
      Estée Lauder Companies Faces Class Action Lawsuit
      La Roche-Posay Launches Matte Moisturizer for Oily Skin
      Happi

      Latest Breaking News From Happi

      Spate Announces Launch of French Data, New Color Complexion Trends Report
      Gojo Creates New All-Weather Purell Dispenser Built for Outdoor High Traffic Locations
      Women in Flavor and Fragrance Present 2022 Recognition Awards Dinner June 16
      Ink World

      Latest Breaking News From Ink World

      NAPIM’s Virtual Digital & Emerging Technologies Conference is Back, June 14–15, 2022
      CEMATEX Introduces Online Business Platform to Connect Global Textile Community
      PICO Chemical Celebrates 46 Years
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Teklynx software helps Top Clean Injection validate labels
      Zeller+Gmelin named Berry Global’s 2021 Ink Supplier of the Year
      Videojet and Loftware partner to accelerate labeling automation
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod
      Ekso Bionics Names Jerome Wong as Interim CFO
      Exactech Completes First Surgeries Using Next-Gen Cage Glenoid
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      ams OSRAM Introduces New Horticulture LEDs
      Avery Dennison Launches AD Twist U7XM Inlays
      ARPA-E Funding Drives Innovation, Industry Partnerships at NREL

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login